Young KwangChaeMD

PubMed

• SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer.
  Guadarrama, E., Ferri, W., Othus, M., Lopez, G., Patel, S., Chae, Y., Dennis, M., Powers, B., Liao, C., George, T., Sharon, E., Ryan, C., Blanke, C., Kurzrock, R.> ;Cancer. 2024 Feb 15
• A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia.
  Megan Othus, David Mutch, Wolfram Samlowski, Elad Sharon, Gabby Lopez, Melissa Plets, Patel, S., Chae, Y., Dennis, M., Gordon, S., Robinson, W., Ryan, C., Blanke, C., ...> ;Clinical Cancer Research. 2024 Jan 5
• 1 citations
  Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
  Ryan D Gentzler, Nisha A Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Nasser H Hanna, Young Kwang Chae, Marianna Koczywas, Irene B Helenowski, Jyoti D Patel> ;The Oncologist. 2024 Jan 5
• 6 citations
  A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical Trials.
  Moataz A S Soliman, Linda C Kelahan, Michael Magnetta, Hatice Savas, Rishi Agrawal, Ryan J Avery, Pascale Aouad, Benjamin Liu, Yue Xue, Young K Chae, Riad Salem, Al B ...> ;JCO Clinical Cancer Informatics. 2022 Nov 1
• 5 citations
  Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma.
  Mary Towner, Karen Novak, Young Kwang Chae, Daniela Matei> ;Gynecologic Oncology Reports. 2022 Aug 1
• 2 citations
  Safety and Tolerability of MEDI0562, an OX40 Agonist mAb, in Combination with Durvalumab or Tremelimumab in Adult Patients with Advanced Solid Tumors.
  Jonathan W Goldman, Sarina A Piha-Paul, Brendan Curti, Katrina S Pedersen, Todd M Bauer, Stefanie L Groenland, Richard D Carvajal, Vaishali Chhaya, Gray Kirby, Kelly M...> ;Clinical Cancer Research. 2022 Sep 1
• 8 citations
  Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
  Cyra Y Kang, Samantha E Duarte, Hye Sung Kim, Eugene Kim, Jonghanne Park, Alice Daeun Lee, Yeseul Kim, Leeseul Kim, Sukjoo Cho, Yoojin Oh, Gahyun Gim, Inae Park, Dongy...> ;The Oncologist. 2022 Jun 8
• 7 citations
  Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience.
  Lorenzo Gerratana, Michael Movarek, Firas Wehbe, Neelima Katam, Devalingam Mahalingam, Jeannine Donahue, Ami Shah, Young K Chae, Mary Mulcahy, Dean Tsarwhas, Victoria ...> ;JCO Precision Oncology. 2022 Jun 1
• 4 citations
  Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literat...
  Gahyun Gim, Yeseul Kim, Yeonggyeong Park, Min Jeong Kim, Myungwoo Nam, Woojung Yang, Samantha E Duarte, Chan Mi Jung, Elena Vagia, Pedro Viveiros, Young Kwang Chae> ;The Oncologist. 2022 Jul 5
• 5 citations
  Artificial Intelligence-Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non-Small-Cell Lung Cancer.
  Jonghanne Park, Jewel Park, Grace Lee, Hye Sung Kim, Kyunghyun Paeng, Sanghoon Song, Gahee Park, Chan-Young Ock, Young Kwang Chae, Cho, H., Hyung-Gyo Cho> ;The American Journal of Pathology. 2022 Apr 1
• 15 citations
  Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy.
  Yeonggyeong Park, Min Jeong Kim, Na Hyun Kim, Leeseul Kim, Seung Pyo Daniel Hong, Emma Yu, Young Kwang Chae, Cho, H., Yoonhee Choi, Hyung-Gyo Cho> ;Journal for Immunotherapy of Cancer. 2022 Mar 1
• 6 citations
  Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.
  Eun-Joo Park, Hyo-Jung Park, Kyung-Won Kim, Chong-Hyun Suh, Changhoon Yoo, Young-Kwang Chae, Sree Harsha Tirumani, Nikhil H Ramaiya> ;Cancers. 2022 Feb 4
• 81 citations
  Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2.
  Lamiaa El-Shennawy, Andrew D Hoffmann, Nurmaa Khund Dashzeveg, Kathleen M McAndrews, Paul J Mehl, Daphne Cornish, Zihao Yu, Valerie L Tokars, Vlad Nicolaescu, Anastasi...> ;Nature Communications. 2022 Jan 20
• 5 citations
  Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma: A Systemic Review and Meta-Analysis.
  Jong Keon Jang, Junhee Pyo, Chong Hyun Suh, Hye Sun Park, Young Kwang Chae, Kyung Won Kim> ;Frontiers in Oncology. 2022 Jan 1
• 31 citations
  A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade ...
  Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D. Miller, Rashmi Chugh, Scott M. Schuetze, Mary D. Chamberlin, Barbara J Haley, Anna Maria Storniolo, Mridula P ...> ;Clinical Cancer Research. 2021 Oct 29
• 3 citations
  Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherap...
  Jonghanne Park, Horyun Choi, Gahyun Gim, Sukjoo Cho, Leeseul Kim, Youjin Oh, Cyra Y. Kang, Yeseul Kim, Dean Tan, Pedro Viveiros, Young Kwang Chae, Dongyup Lee> ;Heliyon. 2021 Sep 1
• 16 citations
  Assessing tumor heterogeneity: integrating tissue and circulating tumor DNA (ctDNA) analysis in the era of immuno-oncology - blood TMB is not the same as tissue TMB.
  Stanislav Fridland, Jaeyoun Choi, Myungwoo Nam, Samuel Joseph Schellenberg, Eugene Kim, Grace Lee, Nathaniel Yoon, Young Kwang Chae> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• 53 citations
  Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1...
  Michael J. Wagner, Megan Othus, Sandip Pravin Patel, Christopher W. Ryan, Ashish Sangal, Benjamin C. Powers, G. Thomas Budd, Adrienne I. Victor, Chung-Tsen Hsueh, Rash...> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• Metastatic CDK12-Mutated Neuroendocrine Tumor of Lung Showed an Exceptional Response to Olaparib and Paclitaxel
  William H. Bae, Jin Young Hwang, Won Kyung Hur, Jaeyoun Choi, Myungwoo Nam, Yoonhee Choi, Leeseul Kim, Eugene Kim, Stanislav Fridland, Heayoon S. Cho, Christmann Low, ...> ;JCO Precision Oncology. 2021 May 3
• 43 citations
  A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.
  Sandip Pravin Patel, Edward Mayerson, Young Kwang Chae, Jonathan R. Strosberg, Jue Wang, Bhavana Konda, Jourdain Hayward, Christine M. McLeod, Helen X. Chen, Elad Shar...> ;Cancer. 2021 Sep 1
• 4 citations
  Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.
  Sukjoo Cho, Jonghanne Park, Misuk Lee, Dongyup Lee, Horyun Choi, Gahyun Gim, Leeseul Kim, Cyra Y. Kang, Youjin Oh, Pedro Viveiros, Elena Vagia, Michael S. Oh, Geum Joo...> ;Translational Lung Cancer Research. 2021 Apr 1
• 38 citations
  Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Met...
  Hyo Jung Park, Kyung Won Kim, Sang Eun Won, Shinkyo Yoon, Young Kwang Chae, Sree Harsha Tirumani, Nikhil H. Ramaiya> ;JAMA Network Open. 2021 Mar 1
• 8 citations
  High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
  Michael S. Oh, Jonathan F. Anker, Young Kwang Chae> ;Cancer Treatment and Research Communications. 2021 Jan 21
• 15 citations
  Comparison of RECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
  Hyo Jung Park, Gun Ha Kim, Kyung Won Kim, Choong Wook Lee, Shinkyo Yoon, Young Kwang Chae, Sree Harsha Tirumani, Nikhil H. Ramaiya> ;Cancers. 2021 Jan 1
• 33 citations
  The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
  Michael S. Oh, Alex Guzner, Derek A. Wainwright, Nisha Mohindra, Young Kwang Chae, Amir Behdad, Victoria M. Villaflor> ;Clinical Lung Cancer. 2021 Jan 1
• Join now to see all